Experience with Ceritinib for ALK+ NSCLC
Alice Shaw, MD, PhD; Tony Mok, MD; and David Spigel, MD, provide insight on the use of ceritinib after progression of ALK-positive non–small cell lung cancer, including their personal experience.
Alice Shaw, MD, PhD; Tony Mok, MD; and David Spigel, MD, provide insight on the use of ceritinib after progression of ALK-positive non–small cell lung cancer, including their personal experience.
